Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|November 9, 2018
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 studyEmilio Iannitto, Monica Bellei, Sandy Amorim, et al.
The Lancet. Oncology|January 20, 2019
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 studyRené-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
The Lancet. Oncology|February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohortsSarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
Blood Advances|August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Cédric Rossi, Pierre Sesques, et al.
The Journal of Clinical Investigation|May 27, 2021
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogrammingSylvain Carras, Dimitri Chartoire, Sylvain Mareschal, et al.
Blood Advances|May 12, 2026
Prognostic Value of Combined Baseline FDG PET/CT Radiomic Parameters in Primary Mediastinal B-Cell LymphomaPierre Decazes, Cedric Rossi, Pierre Sesques, et al.
Blood Advances|September 18, 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACEVincent Camus, Mathieu Viennot, Pierre-Julien Viailly, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Blood Cancer Journal|September 23, 2024
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphomaEce Özoğul, Anna Montaner, Melina Pol, et al.
Pageof 15